Where do we go from hereCXR had quite a few challenges befiore Brexit. Now operating in the new environment it's going to face many more challenges. Take for example regulations, drug approval mechanism, legal and adminstration nightmares.,, currency fluctuations Taking these points into consideration, I don't think anyone in their right mind would even contemplate buying this company.